dehydroretronecine has been researched along with cysteine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, JR; Hsia, MT; Robertson, KA; Seymour, JL | 1 |
Jones, AD; Lamé, MW; Pan, LC; Segall, HJ; Wilson, DW | 1 |
Fu, PP; He, X; Ma, L; Xia, Q | 1 |
3 other study(ies) available for dehydroretronecine and cysteine
Article | Year |
---|---|
Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione.
Topics: Alkylation; Binding Sites; Carcinogens; Chemical Phenomena; Chemistry; Chromatography; Cysteine; Glutathione; In Vitro Techniques; Magnetic Resonance Spectroscopy; Monocrotaline; Pyrrolizidine Alkaloids; Spectrum Analysis; Sulfhydryl Compounds | 1977 |
COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
Topics: Animals; Body Weight; Cysteine; Glutathione; Lung; Male; Monocrotaline; Pulmonary Heart Disease; Rats; Rats, Sprague-Dawley | 1993 |
7-cysteine-pyrrole conjugate: A new potential DNA reactive metabolite of pyrrolizidine alkaloids.
Topics: Animals; Cysteine; DNA; DNA Adducts; Glutathione; Humans; Male; Microsomes, Liver; Monocrotaline; Pyrrolizidine Alkaloids; Rats, Inbred F344; Tandem Mass Spectrometry | 2016 |